Sarah B Kavanagh is Director of Bausch & Lomb Corp. Currently has a direct ownership of 53,699 shares of BLCO, which is worth approximately $617,538. The most recent transaction as insider was on May 27, 2025, when has been sold 20,338 shares (Common Shares, no par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.7K
60.96% 3M change
187.7% 12M change
Total Value Held $617,538

SARAH B KAVANAGH Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 27 2025
BUY
Grant, award, or other acquisition
-
20,338 Added 27.47%
53,699 Common Shares, no par ...
Aug 02 2024
BUY
Grant, award, or other acquisition
-
14,696 Added 30.58%
33,361 Common Shares, no par ...
May 04 2023
BUY
Grant, award, or other acquisition
-
12,857 Added 40.79%
18,665 Common Shares, no par ...
Apr 24 2023
SELL
Payment of exercise price or tax liability
$114,567 $17.12 p/Share
6,692 Reduced 53.54%
5,808 Common Shares, no par ...
May 10 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 50.0%
12,500 Common Shares, no par ...

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
SBK

Sarah B Kavanagh

Director
Bridgewater, NJ

Track Institutional and Insider Activities on BLCO

Follow Bausch & Lomb Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCO shares.

Notify only if

Insider Trading

Get notified when an Bausch & Lomb Corp insider buys or sells BLCO shares.

Notify only if

News

Receive news related to Bausch & Lomb Corp

Track Activities on BLCO